| Long name | SKIL Primary Polyclonal Antibody |
| Also known as | SKIL PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | SnoN |
| Specificity | SNON2, This antibody will recognize Isoform SNOA, and SNOI, This is a highly specific antibody against SnoN |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 300-350/684 |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human SKIL |
| Gene ID number | 6498 |
| Swiss Prot | P12757 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | May have regulatory role in cell division or differentiation in response to extracellular signals |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | SKIL, Ski-like protein, Ski-related oncogene, Ski-related protein, SnoA, SnoI, SnoN, SNO |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | SKIL |
| Short name | SKIL Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | v-ski sarcoma viral oncogene homolog (avian)-like oncogene (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | DNA-templated and biological process this GO :0006367 and transcription initiation from RNA polymerase II promoter and biological process this GO :0007050 and cell cycle arrest and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007283 and spermatogenesis and biological process this GO :0007519 and skeletal muscle tissue development and biological process this GO :0010467 and gene expression and biological process this GO :0016605 and PML body and cellular component this GO :0019904 and protein domain specific binding and molecular function this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0032403 and protein complex binding and molecular function this GO :0034097 and response to cytokine and biological process this GO :0042981 and regulation of apoptotic process and biological process this GO :0043234 and protein complex and cellular component this GO :0045596 and negative regulation of cell differentiation and biological process this GO :0046332 and SMAD binding and molecular function this GO :0046677 and response to antibiotic and biological process this GO :0050772 and positive regulation of axonogenesis and biological process this GO :0070207 and protein homotrimerization and biological process this GO :0070208 and protein heterotrimerization and biological process this GO :0070306 and lens fiber cell differentiation and biological process this GO :0070848 and response to growth factor and biological process this GO :1902043 and positive regulation of extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :1902231 and positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage and biological process, SKIL and IDBG-636450 and ENSBTAG00000004154 and 527910, SKIL and IDBG-64482 and ENSG00000136603 and 6498, SMAD binding, SNO and SnoA and SnoI and SnoN, Skil and IDBG-136318 and ENSMUSG00000027660 and 20482, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001669 and acrosomal vesicle and cellular component this GO :0001825 and blastocyst formation and biological process this GO :0002260 and lymphocyte homeostasis and biological process this GO :0003682 and chromatin binding and molecular function this GO :0003714 and transcription corepressor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006351 and transcription, this GO :0003682: chromatin binding, this GO :0003682: chromatin binding and also this GO :0003714: transcription corepressor activity and also this GO :0005515: protein binding and also this GO :0019904: protein domain specific binding and also this GO :0032403: protein complex binding and also this GO :0046332: SMAD binding, this GO :0003714: transcription corepressor activity, this GO :0005515: protein binding, this GO :0019904: protein domain specific binding, this GO :0032403: protein complex binding, this GO :0046332: SMAD binding, SKI-like oncogene |
| Identity | 10897 |
| Gene | SKIL |
| Long gene name | SKI like proto-oncogene |
| Synonyms gene name | SKI-like oncogene |
| Synonyms | SNO SnoN SnoA |
| Locus | 3q26, 2 |
| Discovery year | 1997-11-28 |
| GenBank acession | X15217 |
| Entrez gene record | 6498 |
| Pubmed identfication | 2762147 |
| RefSeq identity | NM_005414 |
| Classification | SKI transcriptional corepressors |
| Havana BLAST/BLAT | OTTHUMG00000158831 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue